The adhd therapeutics market is anticipated to reach USD 19.8 Billion by 2032 at 7.9% CAGR during the forecast period 2023-2032. The ADHD therapeutics market witnesses robust growth, driven by rising diagnoses and treatment awareness. Valued at billions annually, this sector evolves with innovations in medication, behavioral therapy, and non-pharmacological interventions. Stimulants...